Labcorp Holdings Inc. (NYSE: LH) Stock Analysis & Fundamentals | ScreenerHero

Create free account

LHLabcorp Holdings Inc.

NYSE · US · Healthcare · Diagnostics & Research · labcorp.com

281.94USD+3.66%Mkt Cap: 23.12B $P/E: 24.971d ago

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, bloo…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap23.12B $

Enterprise Value29.45B $

Revenue (TTM)14.14B $

Gross Profit4.01B $

Net Income (TTM)876.50M $

Revenue/Share170.67 USD

Last Price281.94 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees71.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)24.97

P/E (Forward)14.52

PEG1.17

EV/EBITDA13.07

EV/Revenue2.08

P/S1.63

P/B2.66

EPS (TTM)11.29

EPS (Forward)19.41

52W Range

241.8177% of range293.72

52W High293.72 USD

52W Low241.81 USD

Profitability

Gross Margin28.76%

Oper. Margin10.95%

EBITDA Margin15.93%

Profit Margin6.28%

ROE10.17%

ROA4.77%

Growth

Revenue Growth5.80%

Earnings Growth32.90%

Cash Flow & Leverage

Operating CF1.64B $

CapEx (TTM)434.50M $

FCF Margin8.08%

FCF Yield4.94%

Net Debt6.31B $

Net Debt/EBITDA2.80

Balance Sheet

Debt/Equity0.76

Current Ratio1.73

Quick Ratio1.30

Book Value/Sh106.06 USD

Cash/Share11.96 USD

Dividends

Fwd Div Rate2.880 USD

Trail. Div Rate2.880 USD

Div. Yield1.06%

5Y Avg Yield—

Payout Ratio25.51%

Ex-Div DateAug 28, 2026

Pay DateSep 11, 2026

Splits

Last Split1164:1000

Split DateJul 3, 2023

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)312.35 USD

Upside (mean)+10.8%

Target Range270.00 USD – 340.00 USD

$270.00+10.8% to mean$340.00

# Analysts17

Ownership

Shares Out.82.00M

Float81.60M

Insiders0.35%

Institutions100.98%

Short Interest

Short Ratio4.4d

Short % Float3.46%

Short % Out.3.45%

Shares Short2.83M

Short (prev mo.)3.43M

Technical

SMA 50265.01 (+6.4%)

SMA 200267.31 (+5.5%)

Beta0.86

S&P 52W Chg19.63%

Avg Vol (30d)439.85K

Avg Vol (10d)558.43K

Technical Indicators

RSI (14)61.1

MACD3.8081

MACD Signal4.2483

MACD Hist.-0.4402

BB Upper293.67 USD

BB Middle273.43 USD

BB Lower253.19 USD

BB Width14.81%

ATR (14)7.190 USD

Vol Ratio (20d)0.93x